Anda hosted its 10th annual Supply Chain Symposium, a two-day event leading into NACDS Annual. Anda’s annual event featured 450 different meetings between retailers and vendors, and fostered networking opportunities with key stakeholders from corporations representing retail pharmacy, hospital and long-term care, together with manufacturers representing generic and brand pharmaceuticals, as well as OTC products.
Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.
L’Oréal’s efforts have put sustainable product innovation front and center, pledging that all of its new or renovated products will have an improved social or environmental profile by 2020.
Casey Carl, who departs his position as chief innovation and strategy officer, effective May 5, joined the company in 1997, and has held various positions in merchandising, negotiations, operations and digital.
José (Joe) E. Almeida has more than 25 years of experience in health care, including medical devices, consumer health products, surgical instruments and biopharmaceuticals.
Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg are the generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 mg, 8 mg and 16 mg, originally marketed by Schering.
National Association of Chain Drug Stores president and CEO Steve Anderson writes about how the organization’s engaged membership constantly fuel's reinvention in how NACDS navigates business, politics and policy.
As Mother’s Day approaches, Hallmark is rolling out its latest greeting card innovation, as well as new designs for its Signature line of cards and a millennial-targeted marketing campaign.
Drugs are used for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination.